medigraphic.com
ISSN 0188-9796 (Print)

2011, Number 2

<< Back Next >>

Rev Endocrinol Nutr 2011; 19 (2)

Tumor size is not associated with postoperative pituitary hormonal deficiencies in children with craniopharyngiomas

Bahena-García AL, Tamez-Pérez HE, Sánchez-Sánchez LM, Quintanilla-Flores DL, Hernández-Coria MI, Cisneros-Franco JM, Palacios-Saucedo G, Escudero-Rendón AJ

Language: Spanish
References: 20
Page: 58-61
PDF size: 89.03 Kb.


ABSTRACT

Background: Craniopharyngioma is the third most common intracranial tumor in childhood and the most common pediatric tumor in the sellar region. After surgery, most patients develop hormonal deficiencies that require treatment. Objective: To evaluate whether tumor size over 4 cm is associated with the development of postoperative pituitary hormonal deficiencies in children with craniopharyngioma. Research design and methods: We included pediatric patients with the diagnosis of craniopharyngioma who underwent surgery between March 2007 and March 2009. We analyzed variables such as age, gender, type of surgery, neurologic deficit before surgery and postoperative pituitary hormonal deficiencies. The patients were divided according to tumor size in group 1 (≤ 4 cm) and group 2 (› 4 cm). Results: Twenty-two patients were included, 13 in group 1 and 9 in group 2. We did not find statistical differences between tumor size and age, gender, type of surgery and neurologic deficit. When analyzing each hormonal deficiency we did not find statistical differences between these and the variables studied. Conclusions: No associations were found between tumor size and postoperative pituitary hormonal deficiencies in children with craniopharyngioma.


REFERENCES

  1. Halac I, Zimmerman D. Endocrine manifestations of craniopharyngioma. Childs Nerv Syst 2005; 21: 640-648.

  2. Lena G, Paredes AP, Scavarda D, Giusiano B. Craniopharyngioma in children: Marseille experience. Childs Nerv Syst 2005; 21: 778-784.

  3. Karavitaki N, Cudlip S, Adams C. Craniopharyngiomas. Endocr Rev 2006; 27: 371-397.

  4. Müller H. Childhood craniopharyngioma. Horm Res 2008; 69: 193-202.

  5. Müller H, Sörensen N. Childhood craniopharyngioma. Recent advances in diagnosis and treatment. Dtsch Arztebl 2006; 103: 2634-2640.

  6. Sklar CA. Craniopharyngioma: Endocrine abnormalities at presentation. Ped Neurosurg 1994; 21: 18-20.

  7. Vries LD, Lazar L, Phillip M. Craniopharyngioma: Presentation and endocrine sequelae in 36 children. J Ped Endocrinol Metab 2003; 16: 703-710.

  8. Kendall-Taylor P, Jönsson PJ, Abs R et al. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma. Eur J Endocrinol 2005; 152: 557-567.

  9. Elliott RE, Wisoff JH. Successful surgical treatment of craniopharyngioma in very young children. J Neurosurg Pediatrics 2009; 3: 397-406.

  10. Yaşargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. J Neurosurg 1990; 73: 3-11.

  11. Kumar-Gupta D, Ojha B, Sarkar C, Mahapatra A, Mehta V. Recurrence in craniopharyngiomas: Analysis of clinical and histological features. J Clin Neuroscience 2005; 13: 438-442.

  12. Salas-Mallea A, Burgoa-Medrano N, Rocha-Fernández C. Craneofaringioma, a propósito de un caso. Rev Soc Bol Ped 2006; 45: 98-101.

  13. Álvarez C, Rodríguez R, Wong P et al. Nueva alternativa en el manejo del craneofaringioma sólido quístico. Anales de la Facultad de Medicina 1999; 60: 293-297.

  14. Müller H, Emser A, Faldum A, Bruhnken G, Etavard N, Gebhardt U. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004; 89: 3298-3305.

  15. Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab 2011; 96: 1981-1991.

  16. Adamson T, Wiestler O, Kleihues P, Yasargil G. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 1990; 73: 12-74.

  17. Pereira AM, Schmid EM, Schutte PJ et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol 2005; 62: 197-204.

  18. Duff JM, Meyer FB, Ilstrup DM, Laws ERJ, Schleck CD, Scheithauer BW. Long-term outcomes for surgically resected craniopharyngiomas. Neurosurgery 2000; 46: 291.

  19. Weiner HL, Wisoff JH, Rosenberg ME et al. Craniopharyngiomas: A clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994; 35: 1001-1011.

  20. Hoffman HJ, Silva MD, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992; 76: 47-52.




2020     |     www.medigraphic.com